ESR2 and neurodegenerative disease: The weak association between the anti-inflammatory effects and ERα/ERβ ligands suggested the potential use of ERα and ERβ ligands to treat several neurodegenerative diseases with a small inflammatory component, and the administration of anti-inflammatory agents in combination with ERα and ERβ ligands was proposed as a treatment for significant inflammatory diseases.